These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 417508)

  • 1. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)].
    Dreher R; Helmke K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
    Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
    Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
    Wager O
    Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antinuclear factors in rheumatoid arthritis (RA): differentiation of the binding pattern, the H and L chains and demonstration of complement fixation by means of indirect immunofluorescence].
    Dreher R
    Verh Dtsch Ges Rheumatol; 1978; 5():103-6. PubMed ID: 100982
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
    Nguyen CP; Cao VV; Fehér J; Gergely P
    Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S; Ritchie RF
    J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complement system in disseminated lupus erythematosus].
    Vasquez JJ; Fontan G; Gil A; Barbado J; Alvarez I; Ojeda JA
    Rev Rhum Mal Osteoartic; 1977 Dec; 44(12):725-31. PubMed ID: 76330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interactions between rheumatoid factors and antinuclear autoantibodies: their occurrence in a concealed state in rheumatoid disease (arthritis); effect of D-penicillamine].
    Mach PS; Delbarre F; Piatier D
    C R Seances Acad Sci D; 1980 Feb; 290(8):575-8. PubMed ID: 6767559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune deposits in the skin of patients with rheumatoid arthritis.
    McGill PE; Brougham PA; Tulloch J
    J Rheumatol; 1984 Aug; 11(4):454-6. PubMed ID: 6384506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies of the demonstration of antinuclear factors by immunofluorescence and antiglobulin consumption tests].
    Schmidt K; Mueller-Eckhardt C; Becker W
    Verh Dtsch Ges Rheumatol; 1969; 1():251-8. PubMed ID: 4934585
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of T cell subtyping to distinguish rheumatoid arthritis from systemic lupus erythematosus.
    Traycoff RB; Rogers WW; Gregory SA
    J Rheumatol; 1981; 8(3):494-7. PubMed ID: 6974781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential expression of the systemic lupus erythematosus-associated idiotype 8.12 in sera containing monoclonal immunoglobulins.
    Livneh A; Preud'Homme JL; Solomon A; Diamond B
    J Immunol; 1987 Dec; 139(11):3730-3. PubMed ID: 3119715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the immunoglobulin type of complement fixing and non-fixing anti-nuclear factors].
    Peltier AP; Strejcek G
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):787-95. PubMed ID: 4189485
    [No Abstract]   [Full Text] [Related]  

  • 16. [Demonstration of antinuclear factors using the immunologic enzyme technic].
    Storch H
    Z Gesamte Inn Med; 1973 Jan; 28(2):29-32. PubMed ID: 4120838
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological studies in systemic lupus erythematosus.
    Jin OC; Jacob E; Chua D; Lan YS; Hsii FP
    J Med Assoc Thai; 1978 Jan; 61 Suppl 1():10-7. PubMed ID: 304878
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoglobulins and complement in systemic lupus erythematosus, rheumatoid arthritis and juvenile rheumatoid arthritis].
    Dostal Ts; Shusta A; Gana I; Bardfeld R
    Ter Arkh; 1974; 46(11):98-100. PubMed ID: 4216106
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphologic and immunomorphologic studies in rheumatoid arthritis and systemic lupus erythematosus].
    Wagner T
    Patol Pol; 1984; 35(1):45-64. PubMed ID: 6333663
    [No Abstract]   [Full Text] [Related]  

  • 20. Class specific antinuclear antibodies in systemic lupus erythematosus.
    Savitri K; Sehgal S; Datta BN; Chugh KS
    Indian J Med Res; 1993 Feb; 98():27-9. PubMed ID: 8495986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.